Walking Program in Fatty Liver Children With Phenylketonuria

Launched by CAIRO UNIVERSITY · Dec 2, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how a walking program can help children with two specific health issues: phenylketonuria (PKU) and non-alcoholic fatty liver disease. PKU is a genetic condition that causes a buildup of a substance called phenylalanine in the blood, which can lead to several health problems, including fatty liver. The researchers want to see if regular walking can improve the health of children who have PKU, are obese, and also have fatty liver.

To be part of this study, children need to be diagnosed with PKU, and they should also be dealing with obesity and non-alcoholic fatty liver. Unfortunately, children with heart problems, diabetes, certain neurological disorders, or issues with their lungs or kidneys won't be eligible. If chosen to participate, children will engage in a walking program which may help improve their overall health. This study is currently recruiting participants aged between 3 and 14 years, and it welcomes children of any gender.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • PKU children
• • obese children
• • fatty liver children (non-alcoholic fatty liver)
• Exclusion Criteria:
• • cardiac children
• • diabetic children
• • neurogenic disorders
• • respiratory and renal problems